Phenformin and hyperamylasemia in lactic acidosis.
All cases of lactic acidosis occurring during a 23-month period in a metropolitan teaching hospital were reviewed to ascertain the frequency of hyperamylasemia. Serum amylase activity had been measured in 12 of 26 patients and was elevated in eight (67%). Hyperamylasemia was not significantly more frequent in patients with phenformin-associated lactic acidosis than in patients with lactic acidosis who had not received phenformin. Serum amylase activity did not correlate with the severity of acidosis (arterial pH) or with renal function (serum creatinine).
D000138:Acidosis / Q000097:blood* / Q000139:chemically induced / Q000150:complications; D000328:Adult; D000368:Aged; D000681:Amylases / Q000097:blood*; D005260:Female; D006801:Humans; D007773:Lactates / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced; D010629:Phenformin / Q000009:adverse effects*
D007773:Lactates; D010629:Phenformin; D000681:Amylases